QUOTE AND NEWS
Benzinga  Dec 2  Comment 
IRIDEX Corporation (Nasdaq: IRIX) announced today that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced...
TheStreet.com  Nov 5  Comment 
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.  TheStreet Ratings quantitative algorithm...
Benzinga  Oct 14  Comment 
IRIDEX Corporation (Nasdaq: IRIX) announced today that it will introduce its new family of patented Adjustable & Intuitive Extended Reach (A&I XR) laser probes at the annual meeting of the American Academy of Ophthalmology to be held October 18 -...
StreetInsider.com  Oct 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Iridex+Corp+%28IRIX%29+Receives+U.S.+Patent+for+Disposable+Delivery+Device/9891035.html for the full story.
SeekingAlpha  Aug 2  Comment 
IRIDEX Corporation (NASDAQ:IRIX) Q2 2014 Earnings Conference Call July 31, 2014 05:00 p.m. ET Executives William M. Moore – Interim President and CEO James H. Mackaness – Chief Financial Officer and Chief Operating Officer ...
SeekingAlpha  May 4  Comment 
IRIDEX Corporation (IRIX) Q1 2014 Earnings Conference Call May 1, 2014 17:00 ET Executives Will Moore - Chief Executive Officer Jim Mackaness - Chief Financial Officer and Chief Operating Officer Susan Bruce - Investor Relations ...
SeekingAlpha  Feb 28  Comment 
IRIDEX (IRIX) Q4 2013 Earnings Call February 27, 2014 5:00 pm ET Executives William M. Moore - Chairman, Chief Executive Officer and President Susan Bruce James H. Mackaness - Chief Financial Officer, Chief Operating Officer and...
StreetInsider.com  Jan 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/IRIDEX+Corp.+%28IRIX%29+Reports+Strong+Prelim.+Q4%2C+FY13+Revs/9092643.html for the full story.
SeekingAlpha  Nov 28  Comment 
By Inflection Point Investing LLC: Under-followed by the Street and unknown to most investors, ophthalmology pure-play, Iridex Corp. (IRIX), is both a compelling short-term and long-term investment opportunity. Buttressed by its sterling...





You may also be interested in articles related to IRIDEX (IRIX):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki